TXG logo

10x Genomics (TXG) Total debt

Annual Total Debt:

$82.61M-$12.76M(-13.38%)
December 31, 2024

Summary

  • As of today (June 2, 2025), TXG annual total debt is $82.61 million, with the most recent change of -$12.76 million (-13.38%) on December 31, 2024.
  • During the last 3 years, TXG annual total debt has risen by +$635.00 thousand (+0.77%).
  • TXG annual total debt is now -13.38% below its all-time high of $95.37 million, reached on December 31, 2023.

Performance

TXG Total debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGbalance sheet metrics

Quarterly Total Debt:

$80.07M-$2.54M(-3.07%)
March 31, 2025

Summary

  • As of today (June 2, 2025), TXG quarterly total debt is $80.07 million, with the most recent change of -$2.54 million (-3.07%) on March 31, 2025.
  • Over the past year, TXG quarterly total debt has dropped by -$12.10 million (-13.13%).
  • TXG quarterly total debt is now -97.33% below its all-time high of $3.00 billion, reached on September 1, 2017.

Performance

TXG Quarterly Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGbalance sheet metrics

Total debt Formula

Total Debt = Short Term Debt + Long Term Debt

TXG Total debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-13.4%-13.1%
3 y3 years+0.8%-20.9%
5 y5 years+178.0%+34.3%

TXG Total debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-13.4%+0.8%-21.5%at low
5 y5-year-13.4%+178.0%-21.5%+35.3%
alltimeall time-13.4%+682.4%-97.3%>+9999.0%

TXG Total debt History

DateAnnualQuarterly
Mar 2025
-
$80.07M(-3.1%)
Dec 2024
$82.61M(-13.4%)
$82.61M(-3.8%)
Sep 2024
-
$85.88M(-4.0%)
Jun 2024
-
$89.48M(-2.9%)
Mar 2024
-
$92.18M(-3.3%)
Dec 2023
$95.37M(+0.2%)
$95.37M(-3.2%)
Sep 2023
-
$98.47M(-1.1%)
Jun 2023
-
$99.62M(-2.4%)
Mar 2023
-
$102.04M(+7.2%)
Dec 2022
$95.18M(+16.1%)
$95.18M(-1.1%)
Sep 2022
-
$96.23M(-2.8%)
Jun 2022
-
$99.02M(-2.1%)
Mar 2022
-
$101.17M(+23.4%)
Dec 2021
$81.98M(+30.2%)
$81.98M(+2.2%)
Sep 2021
-
$80.20M(+13.2%)
Jun 2021
-
$70.82M(-2.3%)
Mar 2021
-
$72.50M(+15.1%)
Dec 2020
$62.98M
$62.98M(+2.2%)
Sep 2020
-
$61.59M(+4.1%)
Jun 2020
-
$59.17M(-0.8%)
DateAnnualQuarterly
Mar 2020
-
$59.62M(+100.6%)
Dec 2019
$29.72M(+0.1%)
$29.72M(+0.1%)
Sep 2019
-
$29.69M(+0.1%)
Jun 2019
-
$29.66M(>+9900.0%)
Mar 2019
-
$0.00(-100.0%)
Dec 2018
$29.68M(+181.0%)
$29.68M(>+9900.0%)
Sep 2018
-
$0.00(-100.0%)
Dec 2017
$10.56M
-
Sep 2017
-
$3.00B(+20.2%)
Jun 2017
-
$2.49B(+3.4%)
Mar 2017
-
$2.41B(+11.9%)
Dec 2016
-
$2.15B(-3.1%)
Sep 2016
-
$2.22B(+0.1%)
Jun 2016
-
$2.22B(-5.4%)
Mar 2016
-
$2.35B(+12.4%)
Dec 2015
-
$2.09B(-4.8%)
Sep 2015
-
$2.20B(+3.5%)
Jun 2015
-
$2.12B(-0.6%)
Mar 2015
-
$2.14B(-7.5%)
Dec 2014
-
$2.31B

FAQ

  • What is 10x Genomics annual total debt?
  • What is the all time high annual total debt for 10x Genomics?
  • What is 10x Genomics annual total debt year-on-year change?
  • What is 10x Genomics quarterly total debt?
  • What is the all time high quarterly total debt for 10x Genomics?
  • What is 10x Genomics quarterly total debt year-on-year change?

What is 10x Genomics annual total debt?

The current annual total debt of TXG is $82.61M

What is the all time high annual total debt for 10x Genomics?

10x Genomics all-time high annual total debt is $95.37M

What is 10x Genomics annual total debt year-on-year change?

Over the past year, TXG annual total debt has changed by -$12.76M (-13.38%)

What is 10x Genomics quarterly total debt?

The current quarterly total debt of TXG is $80.07M

What is the all time high quarterly total debt for 10x Genomics?

10x Genomics all-time high quarterly total debt is $3.00B

What is 10x Genomics quarterly total debt year-on-year change?

Over the past year, TXG quarterly total debt has changed by -$12.10M (-13.13%)
On this page